Skip to main content
All lobbying filings

North South Government Strategies F/K/A JDM Public Strategies, LLC

North South Government Strategies F/K/A JDM Public Strategies, LLC filed a Q3 report for McKesson Corporation & Affiliates U.S. Oncology and RX Savings Solutions (Former on October 20, 2025, reporting $30,000 in lobbying income.

Lobbying for McKesson Corporation & Affiliates U.S. Oncology and RX Savings Solutions (Former · Distribution

As filed: NORTH SOUTH GOVERNMENT STRATEGIES F/K/A JDM PUBLIC STRATEGIES, LLC for MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER.

All filings by North South Government Strategies F/K/A JDM Public Strategies, LLC · Everything McKesson Corporation & Affiliates U.S. Oncology and RX Savings Solutions (Former has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 20, 2025
Income
$30,000
What the client paid this registrant for the period.
Client based in
Texas

Official filing document

 Lobbyists on this filing 1
  • ERIC J. SILVA
    Previously held: Legislative Aide, Senate EPW & Senator James Jeffords

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 4
Health Issues

H.R. 3521, Clinical Trial Modernization Act; H.R. 1, One Big Beautiful Bill (Definition clarity around distributors); Drug Shortages; Safe Step Act (not reintroduced in 119th) (Support establishing an exception to medication step-therapy protocol in specified cases).

Medicare/Medicaid

H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness.

Pharmacy

H.R. 3164, Ensuring Community Access to Pharmacist Services Act

Manufacturing

H.R. 2444, Promoting Resilient Supply Chains Act; S. 257, Promoting Resilient Supply Chains

 Bills named in this filing 11
  • H.R. 3521
    Clinical Trial Modernization Act
  • H.R. 1
    One Big Beautiful Bill Act
  • H.R. 2484
    Seniors’ Access to Critical Medications Act of 2025
  • H.R. 879
    Medicare Patient Access and Practice Stabilization Act of 2025
  • H.R. 2120
    ROCR Value Based Program Act
  • S. 1816
    Improving Seniors’ Timely Access to Care Act of 2025
  • H.R. 3514
    Improving Seniors’ Timely Access to Care Act of 2025
  • H.R. 4299
    Protecting Patient Access to Cancer and Complex Therapies Act
  • H.R. 3164
    Ensuring Community Access to Pharmacist Services Act
  • H.R. 2444
    Promoting Resilient Supply Chains Act of 2025
  • S. 257
    Promoting Resilient Supply Chains Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem